FOXO4-DRI 10mg
Longevity & Anti-Aging Research
Original price was: $223.99.$178.99Current price is: $178.99.
FOXO4-DRI 10 mg — a senolytic peptide studied for selectively clearing senescent cells via the FOXO4-p53 pathway. A frontier longevity-research compound.
Specifications
| Content | 10 MG per vial |
|---|---|
| Form | Lyophilized powder |
| Purity | >99% (third-party lab tested) |
| Typical dose | 1 mg daily (reference) |
| Reconstitute | 3 mL bacteriostatic water |
| Application | Laboratory research use only |
Reconstitution calculator
Work out concentration, draw volume, and doses per vial. For laboratory research planning only.
How to read it: on a standard U-100 insulin syringe, 100 IU = 1 ml. The middle figure is the line to draw to. Always confirm against the research protocol. Products are sold for laboratory research use only, not for human consumption.
Description
FOXO4-DRI is a senolytic peptide studied for selectively clearing senescent cells by disrupting the FOXO4-p53 interaction — a frontier longevity-research compound.
Why it stands out
- Senolytic class: studied for selective removal of senescent cells
- Disrupts the FOXO4-p53 interaction in research models
- Studied for selectivity that spares healthy cells
- A frontier tool in ageing and longevity research
Supplied as lyophilised powder, >99% purity, third-party lab-tested with a certificate of analysis on every batch. For laboratory and research use only — not for human or animal consumption.






Reviews
There are no reviews yet.